Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score

BACKGROUND: Transarterial chemoembolization (TACE) is the recommended first-line treatment for intermediate-stage Hepatocellular carcinoma (HCC) patients. However, predicting the survival of HCC patients receiving TACE remains challenging. METHODS: In this retrospective study, we analyzed a total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Baocuo, Wang, Xuewen, Guo, Wanting, Yang, Hongyi, Shi, Yanhong, Chen, Yaying, Gao, Simiao, Chen, Jialin, Liu, Lifang, Lu, Linbin, Chen, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426442/
https://www.ncbi.nlm.nih.gov/pubmed/37588889
http://dx.doi.org/10.2147/JHC.S415770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426442/
https://www.ncbi.nlm.nih.gov/pubmed/37588889
http://dx.doi.org/10.2147/JHC.S415770

Ejemplares similares